Fermenta Biotech granted process patent for plant-based Vitamin D3

Fermenta Biotech, India's leading manufacturer of premium-grade APIs, intermediates, and nutritional premixes for global markets, announced that the Indian Patent Office has formally granted a patent for its invention of a plant-based Vitamin D3.

Fermenta's newly granted patent safeguards its proprietary process for producing plant-based Vitamin D3, marking a significant advancement in its innovation pipeline and reinforcing its leadership in the global Vitamin D3 domain. This market-leading vegan solution responds to the accelerating global demand for ethically sourced, sustainable nutrition and positions Fermenta at the forefront of the plant-based nutrition revolution.

By enabling the production of completely vegan and vegetarian-friendly Vitamin D3, the invention captures emerging opportunities across nutraceutical and food fortification sectors, where sustainable, plant-derived ingredients command premiums and growing market share.

Prashant Nagre, managing director of Fermenta, said, "The grant of this patent is a proud milestone in our journey of innovation. It reflects our dedication to addressing evolving consumer needs with environmentally conscious solutions. Plant-based Vitamin D3 represents the future of nutrition, and this patent reinforces our ability to deliver differentiated offerings that create long-lasting impact for both our partners and society at large. It also strengthens India's role as a hub for pioneering industrial innovation, showcasing how local science can contribute to global wellness."

This milestone not only strengthens Fermenta's competitive moat but also diversifies its pioneering legacy in biotechnology and nutrition, supporting its vision to address global nutrition gaps while maintaining scientific excellence and sustainability leadership.